Porsolt & Partners appoints Dr Mark Duxon as CEO
This article was originally published in Scrip
Executive Summary
Porsolt & Partners Pharmacology (France) has appointed Dr Mark Duxon chief executive officer, effective in September. He has been CEO of the contract research organisation Maccine in Singapore since April 2006. Dr Duxon has also worked at GlaxoSmithKline and Lundbeck.